Clinical Trial Update: A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS) [EARLY_Phase 1]

View source ↗

Summary

A multicenter early-phase study assessed whether plasma exchange can accelerate natalizumab clearance in people with relapsing forms of multiple sclerosis; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Natalizumab (natalizumab)

Snippet

Sponsor: Biogen | Conditions: Relapsing Forms of Multiple Sclerosis | EARLY_Phase 1 | Status: COMPLETED